Novel cationic cardiolipin analogue-based liposome for efficient DNA and small interfering RNA delivery in vitro and in vivo
10.1038/sj.cgt.7700793
Crossref journal-article
Springer Science and Business Media LLC
Cancer Gene Therapy (297)
Bibliography

Chien, P.-Y., Wang, J., Carbonaro, D., Lei, S., Miller, B., Sheikh, S., Ali, S. M., Ahmad, M. U., & Ahmad, I. (2004). Novel cationic cardiolipin analogue-based liposome for efficient DNA and small interfering RNA delivery in vitro and in vivo. Cancer Gene Therapy, 12(3), 321–328.

Authors 9
  1. Pei-Yu Chien (first)
  2. Jinkang Wang (additional)
  3. Danielle Carbonaro (additional)
  4. Sabrina Lei (additional)
  5. Bruce Miller (additional)
  6. Saifuddin Sheikh (additional)
  7. Shoukath M Ali (additional)
  8. Moghis U Ahmad (additional)
  9. Imran Ahmad (additional)
References 33 Referenced 125
  1. Felgner PL, Gadek TR, Holm M, et al. Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure. Proc Natl Acad Sci USA. 1987;84:7413–7417. (10.1073/pnas.84.21.7413) / Proc Natl Acad Sci USA by PL Felgner (1987)
  2. Audouy SA, de Leij LF, Hoekstra D, Molema G . In vivo characteristics of cationic liposomes as delivery vectors for gene therapy. Pharm Res. 2002;19:1599–1605. (10.1023/A:1020989709019) / Pharm Res by SA Audouy (2002)
  3. Pedroso de Lima MC, Neves S, Filipe A, Duzgunes N, Simoes S . Cationic liposomes for gene delivery: from biophysics to biological applications. Curr Med Chem. 2003;10:1221–1231. (10.2174/0929867033457430) / Curr Med Chem by MC Pedroso de Lima (2003)
  4. Barron LG, Uyechi LS, Szoka Jr FC . Cationic lipids are essential for gene delivery mediated by intravenous administration of lipoplexes. Gene Ther. 1999;6:1179–1183. (10.1038/sj.gt.3300929) / Gene Ther by LG Barron (1999)
  5. Barron LG, Gagne L, Szoka Jr FC . Lipoplex-mediated gene delivery to the lung occurs within 60 minutes of intravenous administration. Hum Gene Ther. 1999;10:1683–1694. (10.1089/10430349950017680) / Hum Gene Ther by LG Barron (1999)
  6. Krasnici S, Werner A, Eichhorn ME, et al. Effect of the surface charge of liposomes on their uptake by angiogenic tumor vessels. Int J Cancer. 2003;105:561–567. (10.1002/ijc.11108) / Int J Cancer by S Krasnici (2003)
  7. Uchida E, Mizuguchi H, Ishii-Watabe A, Hayakawa T . Comparison of the efficiency and safety of non-viral vector-mediated gene transfer into a wide range of human cells. Biol Pharm Bull. 2002;25:891–897. (10.1248/bpb.25.891) / Biol Pharm Bull by E Uchida (2002)
  8. Loisel S, Floch V, Le Gall C, Ferec C . Factors influencing the efficiency of lipoplexes mediated gene transfer in lung after intravenous administration. J Liposome Res. 2001;11:127–138. (10.1081/LPR-100108457) / J Liposome Res by S Loisel (2001)
  9. Eliyahu H, Servel N, Domb AJ, Barenholz Y . Lipoplex-induced hemagglutination: potential involvement in intravenous gene delivery. Gene Ther. 2002;9:850–858. (10.1038/sj.gt.3301705) / Gene Ther by H Eliyahu (2002)
  10. Loisel S, Le Gall C, Doucet L, Ferec C, Floch V . Contribution of plasmid DNA to hepatotoxicity after systemic administration of lipoplexes. Hum Gene Ther. 2001;12:685–696. (10.1089/104303401300057405) / Hum Gene Ther by S Loisel (2001)
  11. Tousignant JD, Gates AL, Ingram LK, et al. Comprehensive analysis of the acute toxicities induced by systemic administration of cationic lipid:plasmid DNA complexes in mice. Hum Gene Ther. 2000;11:2493–2513. (10.1089/10430340050207984) / Hum Gene Ther by JD Tousignant (2000)
  12. Zou Y, Zong G, Ling YH, Perez-Soler R . Development of cationic liposome formulations for intratracheal gene therapy of early lung cancer. Cancer Gene Ther. 2000;7:683–696. (10.1038/sj.cgt.7700156) / Cancer Gene Ther by Y Zou (2000)
  13. Stopeck AT, Jones A, Hersh EM, et al. Phase II study of direct intralesional gene transfer of allovectin-7, an HLA-B7/beta2-microglobulin DNA–liposome complex, in patients with metastatic melanoma. Clin Cancer Res. 2001;7:2285–2291. / Clin Cancer Res by AT Stopeck (2001)
  14. Noone PG, Hohneker KW, Zhou Z, et al. Safety and biological efficacy of a lipid–CFTR complex for gene transfer in the nasal epithelium of adult patients with cystic fibrosis. Mol Ther. 2000;1:105–114. (10.1006/mthe.1999.0009) / Mol Ther by PG Noone (2000)
  15. Hatch GM . Cardiolipin: biosynthesis, remodeling and trafficking in the heart and mammalian cells. Int J Mol Med. 1998;1:33–41. / Int J Mol Med by GM Hatch (1998)
  16. Song YK, Liu F, Chu S, Liu D . Characterization of cationic liposome-mediated gene transfer in vivo by intravenous administration. Hum Gene Ther. 1997;8:1585–1594. (10.1089/hum.1997.8.13-1585) / Hum Gene Ther by YK Song (1997)
  17. Gaucheron J, Wong T, Wong KF, Maurer N, Cullis PR . Synthesis and properties of novel tetraalkyl cationic lipids. Bioconjug Chem. 2002;13:671–675. (10.1021/bc0101259) / Bioconjug Chem by J Gaucheron (2002)
  18. Kasireddy K, Ahmad MU, Ali SM, Ahmad I . Synthesis of novel cationic cardiolipin analogues for the optimal delivery of therapeutic agents. Tetrahedron Lett. 2004;45:2743–2746. (10.1016/j.tetlet.2004.02.044) / Tetrahedron Lett by K Kasireddy (2004)
  19. Caplen NJ, Mousses S . Short interfering RNA (siRNA)-mediated RNA interference (RNAi) in human cells. Ann NY Acad Sci. 2003;1002:56–62. (10.1196/annals.1281.007) / Ann NY Acad Sci by NJ Caplen (2003)
  20. Woessmann W, Damm-Welk C, Fuchs U, Borkhardt A . RNA interference: new mechanisms for targeted treatment? Rev Clin Exp Hematol. 2003;7:270–291. / Rev Clin Exp Hematol by W Woessmann (2003)
  21. Lei S, Chien PY, Sheikh S, Zhang A, Ali S, Ahmad I . Enhanced therapeutic efficacy of a novel liposome-based formulation of SN-38 against human tumor models in SCID mice. Anticancer Drugs. 2004;15:773–778. (10.1097/00001813-200409000-00006) / Anticancer Drugs by S Lei (2004)
  22. Skehan P, Storeng R, Scudiero D, et al. New colorimetric cytotoxicity assay for anticancer-drug screening. J Natl Cancer Inst. 1990;82:1107–1112. (10.1093/jnci/82.13.1107) / J Natl Cancer Inst by P Skehan (1990)
  23. Wang J, Guo X, Xu Y, Barron L, Szoka Jr FC . Synthesis and characterization of long chain alkyl acyl carnitine esters. Potentially biodegradable cationic lipids for use in gene delivery. J Med Chem. 1998;41:2207–2215. (10.1021/jm950802i) / J Med Chem by J Wang (1998)
  24. Almofti MR, Harashima H, Shinohara Y, Almofti A, Baba Y, Kiwada H . Cationic liposome-mediated gene delivery: biophysical study and mechanism of internalization. Arch Biochem Biophys. 2003;410:246–253. (10.1016/S0003-9861(02)00725-7) / Arch Biochem Biophys by MR Almofti (2003)
  25. Felgner JH, Kumar R, Sridhar CN, et al. Enhanced gene delivery and mechanism studies with a novel series of cationic lipid formulations. J Biol Chem. 1994;269:2550–2561. (10.1016/S0021-9258(17)41980-6) / J Biol Chem by JH Felgner (1994)
  26. Sakurai F, Nishioka T, Yamashita F, Takakura Y, Hashida M . Effects of erythrocytes and serum proteins on lung accumulation of lipoplexes containing cholesterol or DOPE as a helper lipid in the single-pass rat lung perfusion system. Eur J Pharm Biopharm. 2001;52:165–172. (10.1016/S0939-6411(01)00165-5) / Eur J Pharm Biopharm by F Sakurai (2001)
  27. McLean JW, Fox EA, Baluk P, et al. Organ-specific endothelial cell uptake of cationic liposome–DNA complexes in mice. Am J Physiol. 1997;273:H387–H404. / Am J Physiol by JW McLean (1997)
  28. Anwer K, Kao G, Proctor B, Rolland A, Sullivan S . Optimization of cationic lipid/DNA complexes for systemic gene transfer to tumor lesions. J Drug Target. 2000;8:125–135. (10.3109/10611860008996858) / J Drug Target by K Anwer (2000)
  29. Hofland HE, Shephard L, Sullivan SM . Formation of stable cationic lipid/DNA complexes for gene transfer. Proc Natl Acad Sci USA. 1996;93:7305–7309. (10.1073/pnas.93.14.7305) / Proc Natl Acad Sci USA by HE Hofland (1996)
  30. Kolch W . Meaningful relationships: the regulation of the Ras/raf/MEK/ERK pathway by protein interaction. Biochem J. 2000;351:289–305. (10.1042/bj3510289) / Biochem J by W Kolch (2000)
  31. Storm SM, Brennscheidt U, Sithanandam G, Rapp UR . Raf oncogenes in carcinogenesis. Crit Rev Oncogen. 1990;2:1–8. / Crit Rev Oncogen by SM Storm (1990)
  32. Monia BP, Sasmor H, Johnston JF, et al. Sequence-specific antitumor activity of a phosphorothioate oligodeoxyribonucleotide targeted to human C-raf kinase supports an antisense mechanism of action in vivo. Proc Natl Acad Sci USA. 1996;93:15481–15484. (10.1073/pnas.93.26.15481) / Proc Natl Acad Sci USA by BP Monia (1996)
  33. Mewani RR, Tang W, Rahman A, et al. Enhanced therapeutic effects of doxorubicin and paclitaxel in combination with liposome-entrapped ends-modified raf antisense oligonucleotide against human prostate, lung and breast tumor models. Int J Oncol. 2004;24:1181–1188. / Int J Oncol by RR Mewani (2004)
Dates
Type When
Created 20 years, 8 months ago (Dec. 3, 2004, 5:21 a.m.)
Deposited 3 years, 5 months ago (March 22, 2022, 9:47 a.m.)
Indexed 1 day, 3 hours ago (Aug. 31, 2025, 6:08 a.m.)
Issued 20 years, 8 months ago (Dec. 3, 2004)
Published 20 years, 8 months ago (Dec. 3, 2004)
Published Online 20 years, 8 months ago (Dec. 3, 2004)
Published Print 20 years, 6 months ago (March 1, 2005)
Funders 0

None

@article{Chien_2004, title={Novel cationic cardiolipin analogue-based liposome for efficient DNA and small interfering RNA delivery in vitro and in vivo}, volume={12}, ISSN={1476-5500}, url={http://dx.doi.org/10.1038/sj.cgt.7700793}, DOI={10.1038/sj.cgt.7700793}, number={3}, journal={Cancer Gene Therapy}, publisher={Springer Science and Business Media LLC}, author={Chien, Pei-Yu and Wang, Jinkang and Carbonaro, Danielle and Lei, Sabrina and Miller, Bruce and Sheikh, Saifuddin and Ali, Shoukath M and Ahmad, Moghis U and Ahmad, Imran}, year={2004}, month=dec, pages={321–328} }